Manoj Bapat’s Post

View profile for Manoj Bapat, graphic

Versatile AI Product Management Leader | Healthcare

Check out these powerful insights on GLP-1 medication prescription and dispensing trends based on Truveta RWD. The link for accessing the study report in Truveta Studio is incuded below.

View organization page for Truveta, graphic

70,487 followers

Recently, Truveta Research released the latest installment of their GLP-1 RA monitoring report. The report shows that overall prescription rates and first-time prescriptions for medications that are now commonly being prescribed for weight loss, like semaglutide, tirzepatide, and others, aren't showing any signs of slowing down. Use your LinkedIn credentials to view the report in Truveta Studio: https://tr.vet/4eC6IXD #Semaglutide #Tirzepatide #Liraglutide #GLP1 #GLP1Data #GLP1PrescriptionTrends #PrescriptionTrends #PrescriptionData #HealthData #HealthTech #HealthcareData #HealthcareAI #HealthcareInnovation #AI #Innovation #LLM #MedicalResearch #MedicalTechnology #MedTech #WeightLoss #WeightLossDrugs

Truveta Studio: GLP-1 RA prescription trends monitoring report

Truveta Studio: GLP-1 RA prescription trends monitoring report

login.truveta.com

To view or add a comment, sign in

Explore topics